As a university, KI is Sweden’s single largest centre of medical academic research and offers the country’s widest range of medical courses and programmes.
Researchers at KI are conducting the first Swedish clinical trial investigating psilocybin-assisted therapy for depression. The study, which is the first of its kind in Sweden, aims to evaluate the clinical effect of psilocybin-assisted psychotherapy on depression and to further understand the mechanisms of the treatment. Johan Lundberg is leading this research.
Educational / Training
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates